Clal Insurance Enterprises Holdings LTD Edwards Lifesciences Corp Transaction History

Clal Insurance Enterprises Holdings LTD

  • $11.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$84.3 - $94.31 $758,700 - $848,790
9,000 New
9,000 $831,000
Q3 2023

Nov 06, 2023
BUY
$69.28 - $93.38 $346,400 - $466,900
5,000 New
5,000 $346,000
Q4 2022

Feb 13, 2023
BUY
$68.3 - $87.44 $1.06 Million - $1.36 Million
15,500 New
15,500 $1.16 Million

Others Institutions Holding EW

# of Institutions
1,350
Shares Held
456M
Call Options Held
6.35M
Put Options Held
2.82M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Clal Insurance Enterprises Holdings LTD Portfolio

Follow Clal Insurance Enterprises Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email